YWHAE

Chr 17

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon

Also known as: 14-3-3E, HEL2, KCIP-1, MDCR, MDS

This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 100% identical to the mouse ortholog. It interacts with CDC25 phosphatases, RAF1 and IRS1 proteins, suggesting its role in diverse biochemical activities related to signal transduction, such as cell division and regulation of insulin sensitivity. It has also been implicated in the pathogenesis of small cell lung cancer. Two transcript variants, one protein-coding and the other non-protein-coding, have been found for this gene. [provided by RefSeq, Aug 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.23
Clinical SummaryYWHAE
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 13 VUS of 89 total submissions
📖
GeneReview available — YWHAE
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.23LOEUF
pLI 0.985
Z-score 3.30
OE 0.00 (0.000.23)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.83Z-score
OE missense 0.34 (0.270.43)
49 obs / 145.0 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.23)
00.351.4
Missense OE?0.34 (0.270.43)
00.61.4
Synonymous OE?1.07
01.21.6
LoF obs/exp: 0 / 12.7Missense obs/exp: 49 / 145.0Syn Z: -0.42
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateYWHAE-related developmental delay, seizures, hypotonia and brain abnormalitiesOTHERAD

This gene — mechanism propensity

DN
0.6648th %ile
GOF
0.3887th %ile
LOF
0.4627th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.23
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

89 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic1
VUS13
Likely Benign30
Benign23
1
Pathogenic
1
Likely Pathogenic
13
VUS
30
Likely Benign
23
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
1
0
0
0
1
VUS
0
11
2
0
13
Likely Benign
0
0
18
12
30
Benign
0
0
22
1
23
Total111431368

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

124 pathogenic / likely-pathogenic (of 162) ClinVar copy-number / structural variants overlap YWHAE — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

YWHAE · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →